We found no changes in the concentrations of oxidative modification products in breast cancer patients without the BRCA1 mutation, which corroborates our earlier observations regarding the relationship between cancer, the BRCA1 mutation, and disorders of redox balance. Here, BRCA1 is linked to breast cancer.